In mice injected intravenously with Candida albicans, administration of anti-interleukin-18 (IL-18) antibodies increased the yeast load in the kidneys. There was no effect on the organ load with Candida when gamma interferon (IFN-␥)-deficient mice were treated with anti-IL-18 antibodies, suggesting that the protective effect of IL-18 is mediated through endogenous IFN-␥.
Candida albicans or mannoproteins derived from the yeast cell wall induce gamma interferon (IFN-␥) production by human mononuclear cells, and IFN-␥ is a key cytokine for defense against candidiasis (8) . The important role of endogenous IFN-␥ in resistance to systemic candidiasis has been demonstrated in knockout mice deficient in IFN-␥, which are highly susceptible to C. albicans infection (1) . Moreover, administration of recombinant IFN-␥ to wild-type mice infected with C. albicans improves the outcome of the infection (8) . Interleukin-18 (IL-18) serves as a costimulus for IFN-␥ production in the context of costimulation with microbial products (14) . When endogenous IL-18 is neutralized by administration of antibodies to IL-18 (3), there is little, if any, IFN-␥ production after challenge with endotoxin. These data have led to the hypothesis that IL-18 is important for the host defense against disseminated candidiasis.
The aim of the present study was to investigate whether endogenous IL-18 is involved in host defense against Candida infection. IL-18 bioactivity was blocked by neutralizing antimouse IL-18 antibodies. In addition, we assessed whether the effects of IL-18 during disseminated candidiasis are mediated through production of IFN-␥ by studying IFN-␥-deficient mice with disseminated candidiasis treated with anti-IL-18 antibodies. The role of tumor necrosis factor (TNF) in the subsequent IL-18 synthesis was investigated with mice deficient in TNF and lymphotoxin (LT).
CBA mice (females, 20 to 25 g, 6 to 8 weeks old) were purchased from Jackson Laboratories (Bar Harbor, Maine). IFN-␥ Ϫ/Ϫ mice and their wild-type littermates (BALB/c genetic background) were generously provided by Organon (Oss, The Netherlands). Homozygous TNF Ϫ/Ϫ LT Ϫ/Ϫ and wild-type TNF ϩ/ϩ LT ϩ/ϩ mice (genetic background, C57BL/6J ϫ 129sv) were obtained as mating pairs (kindly provided by F. Amiot, CEA, Fontenay-aux-Roses). Anti-mouse IL-18 polyclonal antibodies were produced in rabbits using recombinant mature murine IL-18 (Peprotech, Rocky Hill, N.J.) (3). Normal rabbit serum (NRS) was used in the control groups.
The mice were injected intravenously (i.v.) with C. albicans (strain UC 820; 10 5 CFU/mouse). EDTA-blood was collected from the retroorbital plexus for plasma IL-18 concentration measurements at various time points: 1, 2, 4, 8, 24, 48, and 72 h after infection. Animals received either 200 l of anti-IL-18 antiserum intravenously 10 min before infection and on days 2 and 4 after infection or a similar volume of NRS. Subgroups of 10 animals were killed on day 1, 3, or 7 of infection. The number of viable Candida cells in the kidneys was determined as previously described (7) and expressed as log CFU per gram of tissue.
IL-18 concentrations were determined by electrochemiluminescence, using a biotinylated rat anti-mouse IL-18 antibody (Igen, Gaithersburg, Md.) and a ruthenilated goat antimouse antibody (Peprotech, Princeton, N.J.). The reaction was quantitated using the Origen 1.5 Analyzer (Igen) (15) . IL-1␤ and TNF-␣ levels were determined by specific radioimmunoassays (11) . Murine IL-6 and IFN-␥ concentrations were measured using commercial enzyme-linked immunosorbent assay kits (Pelikine; CLB, Amsterdam, The Netherlands). Detection limits were 20 pg/ml (TNF, IL-1␣, IL-1␤, and IL-6) and 40 pg/ml (IL-18 and IFN-␥). The differences between groups were analyzed by the Mann-Whitney U test.
IL-18 concentrations were below the detection limit (40 pg/ ml) in both uninfected TNF ϩ/ϩ LT ϩ/ϩ and TNF
mice. Intravenous administration of C. albicans to TNF ϩ/ϩ LT ϩ/ϩ mice induced circulating IL-18 concentrations, which reached peak elevations at 8 h postinfection (279 Ϯ 144 pg/ml) (Fig. 1) . In Candida-infected TNF ϩ/ϩ LT ϩ/ϩ mice, the circulating IL-18 concentrations were significantly higher at 2, 4, 8, and 24 h postinfection than those in uninfected mice. Similar IL-18 concentrations were measured in CBA mice and IFN-␥ ϩ/ϩ BALB/c mice (not shown). TNF and/or LT was required for the induction of IL-18, since the peak of circulating IL-18 levels was absent in TNF Ϫ/Ϫ LT Ϫ/Ϫ mice (Fig. 1) . For TNF Ϫ/Ϫ LT Ϫ/Ϫ mice, the IL-18 concentrations were slightly increased above background levels for uninfected mice at 24 h after infection (98 Ϯ 11 pg/ml), similar to the increase in TNF The role of endogenous IL-18 for the defense against C. albicans infection was investigated by administering neutralizing anti-IL-18 antibodies to the mice prior to infection. C. albicans CFU in the kidneys decreased 10-fold within 7 days of infection in mice injected with NRS, whereas neutralization of IL-18 by anti-IL-18 antibodies prevented the elimination of the microorganisms (Fig. 2) . Circulating concentrations of IL-1␣ and IL-6 on days 1 and 3 of infection were not influenced by administration of anti-IL-18 antibodies. However, the increased outgrowth of Candida in the organs of the anti-IL-18-treated mice on day 7 was accompanied by higher circulating concentrations of IL-1␣ and IL-6 than for NRS-treated mice (Fig. 3) . TNF, IL-1␤, and IFN-␥ concentrations were below the detection limit in all samples on days 1, 3, and 7 after infection.
These data imply an important role of endogenous IL-18 in the defense against disseminated candidiasis, and such findings are supported by other studies showing that IL-18 is essential for host defense against mycobacterial infections (16) 
and
Cryptococcus neoformans (5), Leishmania major (13) , and Salmonella infections (9) . In a recent study, it has been shown that recombinant IL-18 restores the Th1 response to C. albicans in caspase-1-deficient mice, which are unable to process the inactive precursors in bioactive IL-18 and IL-1␤ (10). Promising therapeutic properties of IL-18 in experimental infections with C. neoformans (6) or Leishmania spp. (13) have also been suggested.
To investigate whether the effect of IL-18 is mediated through endogenous IFN-␥, neutralizing anti-IL-18 antibodies were given to mice deficient in IFN-␥ before infection with C. albicans. In contrast to the effects in wild-type mice (Fig. 2) , there was no effect of anti-IL-18 antibodies on Candida outgrowth in the kidneys of IFN-␥ Ϫ/Ϫ mice (94% compared to the outgrowth in IFN-␥-deficient mice treated with NRS; P Ͼ 0.05), demonstrating that the effects of endogenous IL-18 during disseminated candidiasis are mediated by IFN-␥. These findings are consistent with previous data demonstrating the importance of IFN-␥ for the protective effects of IL-18 during infection with C. neoformans (6) or Salmonella enterica serovar Typhimurium (9) . The finding that IL-18 has a relatively late effect, on day 7 of infection, is consistent with IFN-␥-mediated stimulation of macrophages, which is known to occur at least 7 days after infection, as has been shown previously with IFN-␥ Ϫ/Ϫ mice (1), whereas no effect of the anti-IL-18 antibodies was found during the first phase of infection, when neutrophilmediated mechanisms are more important (1) . However, since IFN-␥ Ϫ/Ϫ mice are highly susceptible to disseminated candidiasis, it is possible that an additive effect of IL-18 on the antiCandida defense through IFN-␥-independent mechanisms is difficult to substantiate with these mice. IFN-␥-independent effects of IL-18 have been found in lethal endotoxemia and experimental models of streptococcal cell wall arthritis (4, 12) .
In conclusion, endogenous IL-18 plays a protective role in the defense against disseminated infection with C. albicans. The production of IL-18 during disseminated candidiasis requires endogenous TNF and/or LT, and its protective effects are likely mediated through intermediary stimulation of endogenous IFN-␥ synthesis.
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